Dysregulation of Protein Phosphorylation/Dephosphorylation in Alzheimer′s Disease: A Therapeutic Target
Open Access
- 1 January 2006
- journal article
- review article
- Published by Wiley in BioMed Research International
- Vol. 2006 (1) , 31825
- https://doi.org/10.1155/jbb/2006/31825
Abstract
Studies during the last two decades have provided new insights into the molecular mechanism of Alzheimer′s disease (AD). One of the milestone findings in AD research was the demonstration that neurofibrillary degeneration characterized by tau pathology is central to the pathogenesis of AD and other tauopathies and that abnormal hyperphosphorylation of tau is pivotal to neurofibrillary degeneration. This article reviews the recent research advances in tau pathology and the underlying dysregulation of the protein phosphorylation/dephosphorylation system. An updated model of the mechanism of neurofibrillary degeneration is also presented, and a promising therapeutic target to treat AD by correcting dysregulation of protein phosphorylation/dephosphorylation is discussed.Keywords
Funding Information
- National Institutes of Health (AG16760, AG19158, NIRG-03-4721, IIRG-05-13095)
This publication has 165 references indexed in Scilit:
- Bilateral injection of isoproterenol into hippocampus induces Alzheimer‐like hyperphosphorylation of tau and spatial memory deficit in ratFEBS Letters, 2004
- Post-translational modifications of tau protein in Alzheimer’s diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2004
- Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau MutationsJournal of Biological Chemistry, 2004
- PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutationsThe EMBO Journal, 2004
- Up-Regulation of Phosphorylated/Activated p70 S6 Kinase and Its Relationship to Neurofibrillary Pathology in Alzheimer's DiseaseThe American Journal of Pathology, 2003
- RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filamentsPublished by Wiley ,1999
- τ is phosphorylated by GSK‐3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A‐kinaseFEBS Letters, 1998
- Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnnals of Neurology, 1998
- The microtubule binding domain of tau proteinNeuron, 1989
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984